Has Medline Industries, LP had other FDA recalls or enforcement actions?

Yes. Argus HQ has recorded 293 total FDA actions tied to Medline Industries, LP, including 293 recalls and 0 warning letters.

What is the current status of this recall?

Status as recorded by FDA: Ongoing.

Where can I verify this recall directly with FDA?

The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.

FDA Recall Database: Class I Recall: Medline kits containing Huons Co. Bupivacaine HCL in… by Medline Industries, LP

At a glance: Medline Industries, LP recalled Medline kits containing Huons Co. Bupivacaine HCL in Dextrose Injection, USP, labeled as: SPINAL BLOCK 22G QUINCKE 5S BU, Medline Kit SKU DYNJRA9026 on 2026-06-03. FDA classified this action as a Class I recall (recall number Z-2235-2026). Reason for recall: Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints.. Recall status: Ongoing. This is a device-category FDA recall record.

Key facts

Recalling firm	Medline Industries, LP
Manufacturer	Not disclosed in the FDA record.
Brand name	Not disclosed in the FDA record.
Product description	Medline kits containing Huons Co. Bupivacaine HCL in Dextrose Injection, USP, labeled as: SPINAL BLOCK 22G QUINCKE 5S BU, Medline Kit SKU DYNJRA9026
Classification	Class I
Recall number	Z-2235-2026
Report date	Not disclosed in the FDA record.
Status	Ongoing
Reason for recall	Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints.

What this classification means

FDA classifies a recall as Class I when there is a reasonable probability that using the recalled product, or being exposed to it, will cause serious adverse health consequences or death. Class I is FDA's most serious recall classification. In this case, the recalling firm is Medline Industries, LP and the affected product is described in FDA's record as: Medline kits containing Huons Co. Bupivacaine HCL in Dextrose Injection, USP, labeled as: SPINAL BLOCK 22G QUINCKE 5S BU, Medline Kit SKU DYNJRA9026. FDA's stated reason for the recall is: Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints.. The recall is tracked under FDA recall number Z-2235-2026 and carries a status of Ongoing as of the most recent FDA enforcement report. This classification reflects FDA's assessment of the product defect described above, not a prediction about any specific patient outcome. FDA maintains a public enforcement report database so that consumers, physicians, and purchasers can look up the exact product identifiers involved before deciding what to do. Recall status can change while FDA and the recalling firm continue corrective actions, so checking the firm's own notice for the most current guidance is recommended.

What consumers should do

Because FDA has assigned this recall its highest severity classification, anyone who has this product should stop using it immediately, regardless of whether a problem has been noticed yet. Specifically, check whether the product in your possession matches the description on file with FDA -- Medline kits containing Huons Co. Bupivacaine HCL in Dextrose Injection, USP, labeled as: SPINAL BLOCK 22G QUINCKE 5S BU, Medline Kit SKU DYNJRA9026 -- and the recall number Z-2235-2026. If it matches, stop using or distributing it and contact Medline Industries, LP or the point of purchase for return or replacement instructions. Retailers and distributors holding affected inventory should quarantine it and follow the firm's written recall notice. FDA maintains a public enforcement report database so that consumers, physicians, and purchasers can look up the exact product identifiers involved before deciding what to do.

Medline Industries, LP’s FDA history

Argus HQ has recorded 293 total FDA actions tied to Medline Industries, LP: 0 warning letters, 293 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

Has Medline Industries, LP had other FDA recalls or enforcement actions?: Yes. Argus HQ has recorded 293 total FDA actions tied to Medline Industries, LP, including 293 recalls and 0 warning letters.
What is the FDA recall number for this event?: FDA recall number Z-2235-2026.
What is the current status of this recall?: Status as recorded by FDA: Ongoing.
Where can I verify this recall directly with FDA?: The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.

Know if this happens again — we'll email you.

Free. No spam, just recall alerts for what you tell us to watch.

Full FDA history for Medline Industries, LP

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). FDA Recall Database: Class I Recall: Medline kits containing Huons Co. Bupivacaine HCL in… by Medline Industries, LP. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/fda-recall-medline-industries-lp-z-2235-2026

MLA

"FDA Recall Database: Class I Recall: Medline kits containing Huons Co. Bupivacaine HCL in… by Medline Industries, LP." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/recall/fda-recall-medline-industries-lp-z-2235-2026.

Chicago

Argus HQ Research. "FDA Recall Database: Class I Recall: Medline kits containing Huons Co. Bupivacaine HCL in… by Medline Industries, LP." Digital Empire Holdings LLC. Accessed August 29, 2026. https://argushq.ai/recall/fda-recall-medline-industries-lp-z-2235-2026.

BibTeX

@misc{argushq_argushq_ai_recall_fda_recall_medline_industries_lp_z_2235_2026_2026,
  title = {FDA Recall Database: Class I Recall: Medline kits containing Huons Co. Bupivacaine HCL in… by Medline Industries, LP},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/recall/fda-recall-medline-industries-lp-z-2235-2026},
  note = {Accessed: August 29, 2026}
}

Source: FDA.gov — Recalls ↗